Americans for Safe Access

MARCH 24, 2020

With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.

Cannabinoids 241

Cannabinoids Data Safety Patients 241

Cannabis Law Report

DECEMBER 14, 2021

(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. The primary endpoint of our Phase 1 clinical trial was to test and demonstrate safety and tolerability.

Clinical Trials 52

Clinical Trials Safety Data Patients 52

Cannabis Law Report

JUNE 4, 2021

– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. The poster presentation of the data was by Dr. Scott Tagawa , a Professor of Medicine & Urology at Weill Cornell Medicine and an AIkido Pharma Scientific Advisory Board member. Clinical trial information: NCT03276572 ( [link] ).

Data 100

Data Research and Development Clinical Trials Therapy 100

NORML

FEBRUARY 19, 2020

Jobs in the state-licensed cannabis industry rose 15 percent during the past 12 months, and the industry now employs over 243,000 full-time workers, according to data compiled by Leafly.com. According to its 2020 report , the regulated cannabis industry added 33,700 new jobs over the past year.

Legalization 347

Legalization Marijuana Data Safety 347

NORML

JUNE 18, 2019

The administration of herbal cannabis is safe and effective in patients diagnosed with fibromyalgia, according to clinical data published this month in the Journal of Clinical Medicine. Israeli investigators assessed the use of cannabis over a six-month period in 211 patients with the disease.

Patients 279

Patients Therapy Data Safety 279

NORML

MAY 19, 2020

The enactment of adult-use cannabis legalization laws in Colorado and Washington is associated with increased tourism in both states, according to data published in the Journal of Regional Analysis & Policy. Both states experienced their highest jumps in tourism following the advent of retail cannabis sales.

Legalization 339

Legalization Marijuana Data Policy 339

Cannabis Law Report

MAY 18, 2022

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Their participation strengthened the statistical reliability of both the liver safety results and achieved statistical relevance for both sleep and testosterone results.

Safety 52

Safety Hemp Research and Development Data 52

Cannabis Cheri

MARCH 25, 2021

The FDA, which requested science-based data to help inform regulatory decisions for hemp-derived CBD products, has been informed by ValidCare investigators about the positive results of the study. Once completed, safety results of this study will be shared with participating brands and FDA. Read more about the study here.

CBD 235

CBD Data Safety Tincture 235

Cannabis Law Report

MAY 18, 2022

NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE , AMPLIFIES CALLS FOR FDA REGULATION. Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. The study abstract is available here. The methods for both phases were the same.

Safety 52

Safety Hemp Research and Development Data 52

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. The search included studies through 11-May-2020. Eight studies were included, all of which are randomized controlled trials.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

JULY 7, 2021

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

Cannabis Law Report

FEBRUARY 24, 2022

This summary includes results for cannabis inspections from April 1, 2019 to March 31, 2020. Conducted to monitor and verify compliance of the licence holder with the requirements of the Cannabis Act and its regulations. Conducted to assess compliance with promotion requirements as defined in the Cannabis Act and its regulations.

Compliance 52

Compliance Compliance Data Safety 52

NORML

OCTOBER 8, 2019

The enactment of statewide legislation permitting adult cannabis possession and sales is not associated with any significant or long-term uptick in criminal activity, according to data published in the journal Justice Quarterly. Additional information is available from the NORML fact-sheet , ‘Marijuana Regulation and Crime Rates.’

Legalization 217

Legalization Data Safety Retail 217

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.

Clinical Trials 249

Clinical Trials Chronic Pain Cannabinoids Patients 249

Cannabis Law Report

JULY 18, 2019

Hemp Roundtable (“the Roundtable”) appreciates the opportunity to provide comments to FDA in response to its request for scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds.

Hemp 58

Hemp Packaging Advocacy Data 58

Veriheal

NOVEMBER 21, 2023

Veriheal remains dedicated to supporting the next generation of pioneers through its Innovation in Cannabis Scholarship. This year, we are proud to continue our investment in the next generation of cannabis industry leaders. Their one-of-a-kind innovations and solutions are invaluable to the future of cannabis.

Research and Development 106

Research and Development Consumption Education Data 106

Cannabis Law Report

JULY 21, 2022

Patient safety concerns uncovered during an ongoing federal review have led to the suspension of one of two clinical trials for MDMA-assisted psychotherapy currently underway in Canada. A spokesperson told CBC in an email that the study was put on hold “due to concerns for participant safety.” CBC Canada.

Safety 52

Safety Patients Clinical Trials Data 52

NORML

APRIL 12, 2020

According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.

Decriminalization 364

Decriminalization Legalization Marijuana Legislation 364

NORML

AUGUST 29, 2019

Remarks made today by the United States Surgeon General highlighting “the importance of protecting our nation from the health risks of marijuana use in adolescents and during pregnancy” fail to acknowledge the role that a regulated market can play in mitigating the use of cannabis by potentially high-risk populations.

Education 226

Education Data Retail Environment 226

NORML

MAY 22, 2019

Drivers testing positive for the presence of THC in blood do not possess a significantly increased risk of being responsible for a non-fatal motor vehicle accident, according to data published in the journal Addiction. … Our findings … suggest that the impact of cannabis on road safety is relatively small at present time.”

THC 279

THC Data Safety Recreational 279

Cannabis Law Report

OCTOBER 31, 2021

In recent years, cannabis vaporizer cartridges have increased in popularity and availability, and there are concerns regarding exposure to heavy-metal compounds from their use. Noncartridge heating methods of cannabis flower and concentrate were compared, and results indicate that the heating device itself is a source of metal contamination.

Concentrates 98

Concentrates Terpenes Oil Compliance 98

Illinois News Joint

JANUARY 5, 2024

The Illinois Department of Agriculture (IDOA) and Division of Cannabis Regulation today issued a compliance alert for cannabis transporters in Illinois. Product cannot be held overnight by licensed cannabis transporters. A transporter agent shall not open a cannabis container.

Compliance 69

Compliance Compliance Agriculture Policy 69

Veriheal

JANUARY 16, 2024

As the natural remedy of cannabis gains more widespread acceptance and products become increasingly available, its healing properties are slowly gaining acceptance into mainstream culture. This methodology provided valuable real-world information about how CBD is actually applied and received within the CP pediatric community.

Patients 113

Patients CBD Treatment Research and Development 113

Veriheal

MAY 30, 2023

A new 2023 study published in BMJ Supportive & Palliative Care suggests that cannabis could be the answer millions of cancer patients have been looking for. of the patients reported pain as their primary motivation for obtaining a medicinal cannabis prescription. years between May 2015 and October 2018. Interestingly, 72.5%

Medicine 98

Medicine Treatment Patients Data 98

Cannabis Law Report

JANUARY 27, 2020

We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.

Safety 59

Safety CBD Food Seed-To-Sale 59

Cannabis Law Report

NOVEMBER 15, 2021

Andrew Brisbo, Executive Director of Michigan’s Marijuana Regulatory Agency, welcomed as next President of the Cannabis Regulators Association which has expanded to 37 member states and territories. Vice-President Michele Nakata, Supervisor of the Medical Cannabis Dispensary Licensing Program at the Hawaii Department of Health.

Compliance 98

Compliance Compliance Programs Topical 98

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Medicinal Genomics

DECEMBER 10, 2019

MGC), a pioneer in harnessing cannabis genomics to improve agricultural productivity, safety, and transparency of cannabis, to introduce a next generation high-density SNP chip for cannabis and hemp genotyping, breeding, and pathogen testing. These traits are the most important and relevant to the cannabis industry.

Medicine 40

Medicine Agriculture Strains Hemp 40

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Veriheal

JUNE 24, 2022

One of the arguments against the legalization of cannabis is that it may result in more impaired drivers on the road, but emerging research is indicating otherwise. Lauren Dutra, Matthew Farrelly, and their colleagues stated in the study’s report that the relationship between cannabis legalization and traffic safety remains unclear.

Legalization 98

Legalization Education Recreational Data 98

Cannabis Law Report

JULY 8, 2022

California looks to standardize cannabis testing statewide. CALIFORNIA – Delivering on calls to strengthen uniformity in cannabis laboratory testing procedures, the Department of Cannabis Control (DCC) is proposing standards to lab testing methods across the state and is accepting public comments until August 2, 2022.

Cannabinoids 59

Cannabinoids Safety Packaging Cannabis 59

Cannabis Law Report

JULY 26, 2021

This bill mandated that the Division of Criminal Justice in the Department of Public Safety conduct a study of the impacts of Amendment 64, particularly as these relate to law enforcement activities. The information presented here should be interpreted with caution. 13-283 (C.R.S.

Legalization 111

Legalization Data Marijuana Safety 111

NORML

JANUARY 28, 2019

A medical cannabis bill has been filed in the Kentucky General Assembly every year since 2013. Cannabis reform has stalled recently because of opposition from Kentucky’s Senate leadership. Danny Bentley, R-Russell, erroneously compared cannabis to “snake oil remedies of the 1800s,” according to a WDRB-TV report.

Data 186

Data Clinical Trials Chronic Pain Medicine 186

NORML

SEPTEMBER 27, 2019

Updated data provided today by the US Centers for Disease Control reports over 800 cases of acute respiratory distress linked to the use of portable vapor cartridges used to consume certain e-liquids. Further information is available from NORML online here , here , and here. percent (36 percent reported exclusive THC-product use); 56.8

Vaping 206

Vaping Data Retail THC 206

Veriheal

FEBRUARY 19, 2021

Cannabis in America is stuck in a catch-22 situation of epic proportions. The lack of research is one of the many reasons that cannabis remains federally illegal. In order to better understand cannabis, there also needs to be testing standards and regulations in place, which there are not. Fraud Plagues the Cannabis Industry.

Legalization 87

Legalization Research and Development Safety Data 87

Cannabis Law Report

NOVEMBER 26, 2019

The FDA also published a revised Consumer Update detailing safety concerns about CBD products more broadly. This includes ongoing work to obtain and evaluate information to address outstanding questions related to the safety of CBD products, while maintaining the agency’s rigorous public health standards.

Safety 64

Safety Food CBD Oil 64

Cannabis Chronicles

MAY 22, 2019

“We’ll hand them an iPad, and ask them to fill out a couple quick surveys,” said Michael McDonell, chair of WSU’s Collaboration on Cannabis Policy, Research and Outreach. Some of the outcomes we’re interested in looking at, is what kind of cannabis are they using? They’re in a unique space,” McDonell said of the Puyallup tribe.

Medicine 140

Medicine Research and Development Data Collective 140